Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03648918 · ClinicalTrials.gov registry record
Genetics Of Autoimmunity In Type I Diabetes
A clinical trial of Diabetes Mellitus and Type 1 Diabetes, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT03648918: Recruiting study of Diabetes Mellitus and Type 1 Diabetes, sponsored by Medical College of Wisconsin.
NCT03648918 is a study of Diabetes Mellitus and Type 1 Diabetes that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 4,000 participants, above the 1,848-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (116% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03648918, a study of Diabetes Mellitus and Type 1 Diabetes, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to gain more information about the step-by-step process that causes someone to develop type 1 diabetes. Scientists think that a person's own immune system, directed by genetic and environmental factors play a major role in its development. Participation involves a blood draw, a brief medical history questionnaire and measurements of height and weight. Some participants will be asked to return for annual follow-up visits for 10 years.
Primary Outcome
The primary outcome is the development of diabetes as defined by the American Diabetes Association (ADA) based on the presence of symptoms and unequivocal hyperglycemia.
Conditions Studied
Interventions
- OTHER Blood Collection
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2001-08 |
| Est. Completion | 2050-01 |
What NCT03648918 shows while recruiting
NCT03648918 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,848-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (116% higher).
The record links to 4 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Blood Collection is the first listed.
NCT03648918 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03648918 about?
NCT03648918 is a clinical study titled "Genetics Of Autoimmunity In Type I Diabetes". The purpose of this study is to gain more information about the step-by-step process that causes someone to develop type 1 diabetes. Scientists think that a person's own immune system, directed by genetic and environmental factors play a major role in its development. Participation involves a blood ...
What is the current status of trial NCT03648918?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2001-08. Estimated completion is 2050-01.
What conditions does trial NCT03648918 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 1, Type 1 Diabetes Mellitus.
What interventions are being tested in trial NCT03648918?
The interventions under investigation include: Blood Collection (OTHER).
Who is sponsoring clinical trial NCT03648918?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03648918 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03648918's enrollment target sits among peer trials
4,000 16th of 208 higher than 193 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
Rare and Atypical Diabetes Network
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia